Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of full-dose versus half-dose TCA injection in patients with DQST
TCTR20260405005Phase 0Not yet recruiting
- Sponsor
- N/A
- Start
- Jul 2026
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 0 trial of trichloroacetic acid in None (2 arms), sponsored by N/A. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
trichloroacetic acid
Beyond the preview
Go deeper on TCTR20260405005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260405005.